These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21721166)

  • 1. [New data on risks and benefits: beta blockers despite asthma? (interview by Dr. Beate Schumacher)].
    Gillissen A
    MMW Fortschr Med; 2011 Jun; 153(24-25):6. PubMed ID: 21721166
    [No Abstract]   [Full Text] [Related]  

  • 2. Think the impossible: beta-blockers for treating asthma.
    Lipworth BJ; Williamson PA
    Clin Sci (Lond); 2009 Oct; 118(2):115-20. PubMed ID: 19807697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma in the elderly: β-adrenergic receptor blockers may worsen, β-receptor agonists relieve (with caveats).
    Caviglia AG
    J Allergy Clin Immunol; 2011 Jun; 127(6):1639; author reply 1639. PubMed ID: 21489614
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise.
    Chang CL; Mills GD; McLachlan JD; Karalus NC; Hancox RJ
    Intern Med J; 2010 Mar; 40(3):193-200. PubMed ID: 19383058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-agonists, beta-blockers and obstructive airway disease.
    Madalena Esteves M
    Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):375-9. PubMed ID: 16528900
    [No Abstract]   [Full Text] [Related]  

  • 6. [Beta blockers in asthma and COPD--a therapeutic dilemma?].
    Worth H
    Pneumologie; 2001 Feb; 55(2):53-6. PubMed ID: 11268885
    [No Abstract]   [Full Text] [Related]  

  • 7. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction.
    Groenwold RH; de Vries F; de Boer A; Pestman WR; Rutten FH; Hoes AW; Klungel OH
    Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1130-7. PubMed ID: 21953948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary effects of nebivolol.
    Dal Negro R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):329-34. PubMed ID: 19638367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta blockers for patients with lung disease?
    Harv Heart Lett; 2001 Nov; 12(3):2-3. PubMed ID: 11724686
    [No Abstract]   [Full Text] [Related]  

  • 11. New treatments for exercise-induced asthma.
    Hansen-Flaschen J; Schotland H
    N Engl J Med; 1998 Jul; 339(3):192-3. PubMed ID: 9664097
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of beta-blockers in patients with COPD.
    Andrus MR; Holloway KP; Clark DB
    Ann Pharmacother; 2004 Jan; 38(1):142-5. PubMed ID: 14742808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Getting to the heart of asthma: can "beta blockers" be useful to treat asthma?
    Bond RA; Spina D; Parra S; Page CP
    Pharmacol Ther; 2007 Sep; 115(3):360-74. PubMed ID: 17681610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers are safe in patients with chronic obstructive pulmonary disease, but only with caution.
    Cazzola M; Matera MG
    Am J Respir Crit Care Med; 2008 Oct; 178(7):661-2. PubMed ID: 18796649
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].
    Glaab T; Weiss T
    Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-2 adrenergic receptor agonists in asthma treatment].
    Haahtela T; Sorva R
    Duodecim; 1995; 111(8):744-8. PubMed ID: 8681834
    [No Abstract]   [Full Text] [Related]  

  • 17. Many asthma patients experience persistent symptoms despite appropriate clinical and guideline-based treatment with inhaled corticosteroids.
    Mogil J
    J Am Acad Nurse Pract; 2007 Sep; 19(9):459-70. PubMed ID: 17760570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How risky are beta-2 mimetics?].
    Paukstadt W
    MMW Fortschr Med; 2006 Aug; 148(33-34):10. PubMed ID: 16981376
    [No Abstract]   [Full Text] [Related]  

  • 19. [Even in COPD beta blockers can be administered - but not all].
    de Zeeuw J
    MMW Fortschr Med; 2015 Oct; 157(18):44. PubMed ID: 26985506
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-2 adrenergic agonists: focus on safety and benefits versus risks.
    Ortega VE; Peters SP
    Curr Opin Pharmacol; 2010 Jun; 10(3):246-53. PubMed ID: 20452285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.